BPC-157 attenuated lung lesions caused by intratracheal HCl alongside gastric protection, extending its cytoprotective effects to the respiratory system and demonstrating multi-organ protection.
Lungs tooBPC-157 protected lungs from acid damage in addition to its known gut healing — cytoprotection that extends to the respiratory system
What the researchers found
BPC-157 attenuated both intratracheal HCl-induced lung lesions and associated gastric damage in rats, demonstrating cytoprotective effects extending beyond the GI tract to the respiratory system.
Why it matters
Acid aspiration lung injury has no specific treatment. A peptide that protects both lungs and stomach from acid damage could benefit patients at risk of aspiration, including surgical patients and those with GERD.
How the study worked
Animal study in rats. Intratracheal HCl instillation to induce lung and secondary gastric lesions. BPC-157, ranitidine, omeprazole, and other anti-ulcer agents tested for both lung and gastric protection.
What this study cannot tell us
Rat model with acute chemical lung injury. The mechanism of lung protection was not determined. Whether BPC-157 protects against other types of lung injury is unknown.
How to read the evidence
Preliminary animal evidence extending BPC-157's protective effects to a new organ system with clear comparative drug data.
When this study was published
Published in 2001. BPC-157's multi-organ cytoprotection has been further documented across additional organ systems.
The bigger picture
BPC-157's cytoprotection extends to the lungs — another organ system beyond its known gut effects. This broadening pattern suggests BPC-157 activates universal tissue repair mechanisms, not gut-specific ones.
Questions still open
- Could BPC-157 prevent aspiration pneumonitis?
- Does BPC-157 protect against infection-related lung damage?
- What mechanism mediates the lung protection?
Common questions
Can BPC-157 protect the lungs?
Why would a gut peptide help the lungs?
Read the original research
Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats.
Journal of physiology, Paris, 95(1-6), 303-8
Citation
Stancic-Rokotov, D; Slobodnjak, Z; Aralica, J; Aralica, G; Perovic, D; Staresinic, M; Gjurasin, M; Anic, T; Zoricic, I; Buljat, G; Prkacin, I; Sikiric, P; Seiwerth, S; Rucman, R; Petek, M; Turkovic, B; Kokic, N; Jagic, V; Boban-Blagaic, A. (2001). Lung lesions and anti-ulcer agents beneficial effect: anti-ulcer agents pentadecapeptide BPC 157, ranitidine, omeprazole and atropine ameliorate lung lesion in rats.. Journal of physiology, Paris, 95(1-6), 303-8.